High anti-ENO1 and intermediate anti-FUBP1 aAb levels are negative prognostic factors, whereas an increased level of anti-FUBP1 aAb is a good prognostic factor for PDA tumors in the pancreas tail body only. The gene discussed is ENO1; the disease is Patent ductus arteriosus.